​

Bicara Therapeutics Ownership | Who Owns Bicara Therapeutics?

OverviewFinancialsChart

Bicara Therapeutics Ownership Summary

Bicara Therapeutics is owned by 89.19% institutional investors, 0.42% insiders, and 10.40% retail investors. First turn management is the largest institutional shareholder, holding 0% of BCAX shares.

BCAX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBicara Therapeutics89.19%0.42%10.40%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
First turn management---
Marshall wace, llp---
Spire wealth management---
Cinctive capital management lp---
Mrp capital investments---
Maven securities---
Verition fund management---
Advisor group---
Lmr partners llp---
Virtus etf advisers---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
First turn management---
Marshall wace, llp---
Spire wealth management---
Cinctive capital management lp---
Mrp capital investments---
Maven securities---
Verition fund management---
Advisor group---
Lmr partners llp---
Virtus etf advisers---

Top Buyers

HolderShares% AssetsChange
Mrp capital investments---20.00
Advisor group---292.00
Spire wealth management---1.80K
Virtus etf advisers---3.94K
Lmr partners llp---15.15K

Top Sellers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)---1.80M
Alliancebernstein---821.26K
First turn management---346.17K
Marshall wace, llp---67.73K
Maven securities---25.00K

Sold Out

HolderChange
Mrp capital investments-20.00
Advisor group-292.00
Spire wealth management-1.80K
Virtus etf advisers-3.94K
Lmr partners llp-15.15K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20259213.58%48,567,5534.69%891.23%54-10.00%18157.14%
Dec 31, 20248322.06%46,705,50728.51%851.92%62-8.82%7-
Sep 30, 202468-36,343,123-66-68---

Recent Insider Transactions

DateNameRoleActivityValue
Mar 14, 2025Meisner Lara Chief Legal OfficerSell$615.70K
Mar 14, 2025Meisner Lara Chief Legal OfficerSell$405.51K
Sep 16, 2024RA CAPITAL MANAGEMENT, L.P. Buy$30.25M
Sep 16, 2024RA CAPITAL MANAGEMENT, L.P. Buy$2.74M
Sep 17, 2024Flynn James E Possible Members of 10% GroupBuy$630.00K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1-2
2024 Q33-

BCAX Ownership FAQ

Who Owns Bicara Therapeutics?

Bicara Therapeutics shareholders are primarily institutional investors at 89.19%, followed by 0.42% insiders and 10.39% retail investors. The average institutional ownership in Bicara Therapeutics's industry, Biotech Stocks , is 63.96%, which Bicara Therapeutics exceeds.

Who owns the most shares of Bicara Therapeutics?

Bicara Therapeutics’s largest shareholders are First turn management (0 shares, 0%), Marshall wace, llp (0 shares, 0%), and Spire wealth management (0 shares, 0%). Together, they hold 0% of Bicara Therapeutics’s total shares outstanding.

Does Blackrock own Bicara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Bicara Therapeutics.

Who is Bicara Therapeutics’s biggest shareholder by percentage of total assets invested?

First turn management is Bicara Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Bicara Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools